139 related articles for article (PubMed ID: 21458187)
1. Low dose CE-MRA.
Nael K; Moriarty JM; Finn JP
Eur J Radiol; 2011 Oct; 80(1):2-8. PubMed ID: 21458187
[TBL] [Abstract][Full Text] [Related]
2. Non-contrast-enhanced MR angiography of the abdomen.
Miyazaki M; Isoda H
Eur J Radiol; 2011 Oct; 80(1):9-23. PubMed ID: 21330081
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
4. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus.
Pomposelli F
J Vasc Surg; 2010 Sep; 52(3 Suppl):81S-91S. PubMed ID: 20804938
[TBL] [Abstract][Full Text] [Related]
5. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.
Krishnam MS; Tomasian A; Lohan DG; Tran L; Finn JP; Ruehm SG
Clin Radiol; 2008 Jul; 63(7):744-55. PubMed ID: 18555032
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].
Marchand B; Hernandez-Hoyos M; Orkisz M; Douek P
J Mal Vasc; 2000 Dec; 25(5):312-320. PubMed ID: 11148391
[TBL] [Abstract][Full Text] [Related]
7. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced peripheral MRA: technique and contrast agents.
Nielsen YW; Thomsen HS
Acta Radiol; 2012 Sep; 53(7):769-77. PubMed ID: 22843836
[TBL] [Abstract][Full Text] [Related]
9. [Nonenhanced MR angiography techniques].
Lanzman RS; Schmitt P; Kröpil P; Blondin D
Rofo; 2011 Oct; 183(10):913-24. PubMed ID: 21442557
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative imaging in 78 living kidney donors using CE-MRA and DSA].
Lemke U; Taupitz M; Klüner C; Giessing M; Schönberger B; Hamm B; Kröncke TJ
Rofo; 2008 Jan; 180(1):48-54. PubMed ID: 18092278
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II study.
Kittner T; Rudolf J; Fages JF; Legmann P; Aschauer M; Repa I; Alvares MR; Savalegui I; Ittrich H; Geterud K; de Kevviler E; Ayuso J; Lockhart ME; Blum A; Iliasch H; Leisinger G; van Beek EJ; Reid AW; Brown JJ; Yu TC; Flamm SD; Düber C; Judmaier W; Reimer P; Stiskal M; Kramann B; Wolff S; Blankenstein C
Eur J Radiol; 2007 Dec; 64(3):456-64. PubMed ID: 17412546
[TBL] [Abstract][Full Text] [Related]
12. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.
Krishnam MS; Tomasian A; Deshpande V; Tran L; Laub G; Finn JP; Ruehm SG
Invest Radiol; 2008 Jun; 43(6):411-20. PubMed ID: 18496046
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR angiography.
Kilgour DA
Radiol Technol; 1999; 71(2):133-8. PubMed ID: 10582248
[TBL] [Abstract][Full Text] [Related]
16. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography.
Villablanca JP; Nael K; Habibi R; Nael A; Laub G; Finn JP
Invest Radiol; 2006 Nov; 41(11):799-805. PubMed ID: 17035870
[TBL] [Abstract][Full Text] [Related]
17. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries.
Wikström J; Wasser MN; Pattynama PM; Bonomo L; Hamm B; Del Maschio A; Knopp MV; Marchal G; Barentsz JO; Oudkerk M; Hentrich HR; Daprà M; Kirchin MA; Shen N; Spinazzi A; Ahlström H
Invest Radiol; 2003 Aug; 38(8):504-15. PubMed ID: 12874517
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic pitfalls in postinterventional intraarterial magnetic resonance angiography after recanalization of femoropopliteal arterial occlusions.
Huegli RW; Aschwanden M; Kos S; Rasmus M; Jaeger K; Jacob AL; Bilecen D
Acta Radiol; 2008 Dec; 49(10):1129-36. PubMed ID: 19031180
[TBL] [Abstract][Full Text] [Related]
19. Celiomesenteric trunk demonstrated by 3-dimensional contrast-enhanced magnetic resonance angiography.
Lin J
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):472-4. PubMed ID: 16109540
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
Bongartz G; Mayr M; Bilecen D
Eur J Radiol; 2008 May; 66(2):213-9. PubMed ID: 18329834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
